Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect

Hayley Nehoff1, Neha N Parayath1, Laura Domanovitch1

  • 1Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand.

Insights

Nanomedicine shows promise for cancer and inflammation, but faces specificity challenges. Improved designs are enhancing targeted delivery to diseased cells and tissues.

Area of Science:

  • Biomedical Engineering
  • Drug Delivery Systems
  • Nanotechnology

Background:

  • Nanomedicine offers potential for treating cancer and inflammatory diseases.
  • The enhanced permeability and retention (EPR) effect is a key factor in nanomedicine delivery.
  • Current limitations of the EPR effect include lack of specificity and premature drug release.

Purpose of the Study:

  • To review recent advances in nanomedicine design for improved targeting.
  • To highlight emerging technologies that overcome EPR limitations.
  • To discuss the potential of enhanced nanomedicine for specific cell and tissue targeting.

Main Methods:

  • Review of current literature on nanomedicine design and targeting strategies.
  • Analysis of factors limiting the enhanced permeability and retention effect.
  • Case studies of novel nanomedicine platforms demonstrating improved specificity.

Main Results:

  • Nanomedicine designs are increasingly addressing specificity issues.
  • New strategies are emerging to enhance cellular and tissue targeting.
  • Advances show potential to overcome limitations of the EPR effect.

Conclusions:

  • Improved nanomedicine designs are crucial for effective cancer and inflammation therapy.
  • Targeted delivery to specific pathological cells and tissues is becoming more achievable.
  • Emerging nanotechnologies hold significant promise for precision nanomedicine.

Related Concept Videos

Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
351
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
161
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
159
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport01:23

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport

Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
2.5K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.2K
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
2.1K